MicrobiologyAnaerobePeer-reviewed
In vivo efficacy of fidaxomicin against rpoB mutant Clostridioides difficile infection.
Mai Thu Hoai, Yutaro Hitomi, Tsutomu Fujii, Yoshitomo Morinaga
This study evaluates the in vivo efficacy of fidaxomicin against a rpoB mutant strain of C. difficile and finds it remains effective despite reduced susceptibility.
1 citation